RecruitingPhase 4NCT07438444

A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

A Phase 4, Open-Label, Single-Arm, 46-Week Study to Investigate the Safety and Efficacy With Tirzepatide in Adult Indian Participants With Either Type 2 Diabetes or Obesity

Sponsor

Eli Lilly and Company

Enrollment

344 participants

Start Date

Feb 27, 2026

Study Type

INTERVENTIONAL

Conditions

Obesity Diabetes Mellitus, Type 2 Overweight

Summary

The main purpose of this study is to measure the safety and efficacy of tirzepatide in adult participants in India who have type 2 diabetes or who have obesity or overweight without type 2 diabetes. Participation in the study will last about 46 weeks.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Tirzepatide for people with diabetes mellitus, type 2, obesity, and other related conditions. The study is currently recruiting participants at 21 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTirzepatide

Administered SC

Locations(21)

B. J. Medical College & Civil Hospital

Ahmedabad, India

V.S. General Hospital

Ahmedabad, India

Gujarat Endocrine Center

Ahmedabad, India

Jawahar Lal Nehru Medical College

Ajmer, India

Motilal Nehru Medical College Hospital

Allahābād, India

Lifecare Hospital and Research Centre

Bengaluru, India

AIIMS, Bhubaneshwar

Bhubaneswar, India

Sri Ramachandra MedicaL College & Research Institute

Chennai, India

Kovai Diabetes Speciality Center and Hospital

Coimbatore, India

Apollo Excelcare Hospital

Guwahati, India

Osmania Medical College & Hospital

Hyderabad, India

Eternal Heart Care Center and Research Institute

Jaipur, India

K care Hospital

Kanpur, India

Brij Medical Centre Private Limited

Kanpur, India

ILS Hospitals

Kolkata, India

Government Medical College, Kozhikode

Kozhikode, India

Wockhardt Hospitals

Mumbai, India

Shri Krishna Hrudayalaya & Critical Care Centre

Nagpur, India

Sahyadri Super Speciality Hospital

Pune, India

All India Institute of Medical Sciences

Raipur, India

King George Hospital, Andhra Medical College

Visakhapatnam, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07438444

Related Trials

Evaluation of the Care Pathway Offered by the "Chronic Disease Unit" to Obese Patients

NCT065382201 location

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

NCT072258161 location

A Study of LY3971297 in Healthy Participants

NCT061482727 locations

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

NCT06112418124 locations

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

NCT074073481 location